PKA-binding proteins and uses thereof

Details PKA-binding proteins and uses thereof PKA-binding proteins and uses thereof

1998-08-17

1999-11-30

Kemmerer, Elizabeth

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 530350, C07K 14435

Patent

active

059943041

ABSTRACT:
The present invention provides novel PKA-binding polypeptides, nucleic acids that encode the polypeptides and antibodies specifically immunoreactive with the polypeptides.

REFERENCES:
patent: 4568649 (1986-02-01), Bertoglio-Matte
patent: 4766046 (1988-08-01), Abra et al.
patent: 5169637 (1992-12-01), Lenk et al.
patent: 5180713 (1993-01-01), Abra
patent: 5185154 (1993-02-01), Lasic et al.
patent: 5204112 (1993-04-01), Hope et al.
patent: 5252263 (1993-10-01), Hope et al.
patent: 5283173 (1994-02-01), Fields et al.
patent: 5795735 (1998-08-01), Lockerbie et al.
Aldape et al., "Charged Surface Residues of FKBP12 Participate in Formation of the FKBP12-FK506-Calcineurin Complex*", J.Biol.Chem. 267:16029-16032 (1992).
Allen et al., "Cyclosporin: A Therapy for Wegner's Granulomatosis" in ANCA--Associated Vasculitides: Immunological and Clinical Aspects, Gross (ed.) New York: Plenum Press (1993), pp. 473-476.
Belldegrun et al., "Interferon-.alpha. Primed Tumor-Infiltrating Lymphocytes Combined with Interleukin-2 and Interferon-.alpha. as Therapy for Metastatic Renal Cell Carcinoma", J.Urol. 150:1384-1390 (1993).
Boudet et al., "UV-treated polystyrene microtitre plates for use in an Elisa to measure antibodies aginst synthetic peptides" J.Immunol.Meth. 142:73-82 (1991).
Bougneres et al., "Factors Associated With Early Remission Of Type I Diabetes In Children Treated With Cyclosporine", N.Eng.J.Med. 318:663-670 (1988).
Bougneres et al., "Limited Duration of Remission of Insulin Dependency in Children with Recent Overt Type I Diabetes Treated with Low-Dose Cyclosporin", Diabetes 39:1264-1272 (1990).
Bregman et al., "Molecular Characterization of Bovine Brain B75, a High Affinity Binding Protein for the Regulatory Subunit of cAMP-dependent Protein Kinase II.beta.*", J.Biol.Chem. 266:7202-7213 (1991).
Bruton and Koeller, "Recombinant Interleukin-2", Pharmacotherapy 14:635-656 (1994).
Brynskov, "Cyclosporin in Crohn's disease", Dan.Med.Bull. 41:332-344 (1994).
Carr et al., "Follicle-stimulating Hormone Regulation of A-kinase Anchoring Proteins in Granulosa Cells*", J.Biol.Chem. 268:20729-20732 (1993).
Carr et al., "Association of the type II cAMP-dependent Protein Kinase with a Human Thyroid RII-anchoring Protein", J.Biol.Chem.267:13376-13382 (1992).
Carr and Scott, "Blotting and band-shifting: techniques for studying protein-protein interactions", T.I.B.S. 17:246-249 (1992).
Carr et al., "Interaction of the Regulatory Subunit (RII) of cAMP-dependent Protein Kinase with RII-anchoring Proteins Occurs through an Amphipathic Helix Binding Motif*", J.Biol.Chem. 266:14188-14192 (1991).
Carr et al., "Localization of the cAMP-dependent Protein Kinase to the Postsynaptic Densities by A-Kinase Anchoring Proteins", J.Biol.Chem. 267:16816-16823 (1992).
Cheley et al., "Type II Regulatory Subunits of cAMP-dependent Protein Kinase and Their Binding Proteins in the Nervous System of Aplysia californica*", J.Biol.Chem. 269:2911-2920 (1994).
Choi and Targan, "Immunomodulator Therapy in Inflammatory Bowel Disease", Dig.Dis and Sci. 39:1885-1892 (1994).
Clipstone and Crabtree, "Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation", Nature 357:695-697 (1992).
Coghlan et al., "A-Kinase Anchoring Proteins: a key to selective activation of cAMP-responsive events?", Mol.Cell.Biochem. 127:309-319 (1993).
Coglan et al., "Cloning and Characterization of AKAP 95, a Nuclear Protein That Associates with the Regulatory Subunit of Type II cAMP-dependent Protein Kinase*", J.Biol.Chem. 269:7658-7665 (1994).
Cooper et al., "Atopic Dermatitis: Recent Trends in Pathogenesis and Therapy", J.Invest.Derm 102:128-137 (1994).
Cuellar et al., "Treatment of psoriatic arthritis", Balliere's Clin.Rheum. 8:483-498 (1994).
Cyert and Thorner, "Calcineurin-like Activity in Saccharomyces cerevisiae", J.Cell.Biol. 107:841a (1989).
de Groen et al., "Central Nervous System Toxicity After Liver Transplantation", N.Eng.J.Med. 317:861-866 (1987).
DeCamilli et al., "Heterogeneous Distribution of the cAMP Receptor Protein RII in the Nervous System: Evidence for Its Intracellular Accumulation of Microtubules, Microtubule-organizing Centers, and in the Area of the Golgi Complex", J.Cell.Biol. 103:189-203 (1986).
Deeg et al., "Cyclosporine as Prophylaxis for Graft-Versus-Host Disease: A Randomized Study in Patients Undergoing Marrow Transplantation for Acute Nonlymphoblastic Leukemia", Blood 65:1325-1334 (1985).
Dillman, "The Clinical Experience with Interleukin-2 in Cancer Therapy", Cancer Biotherapy 9:183-209 (1994).
Dougados and Torley, "Efficacy of Cyclosproin A in Rheumatoid Arthritis: Worldwide Experience", Br.J.Rheum 32(suppl 1):57-59 (1993).
Durfee et al., "The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit", Genes and Development 7:555-567 (1993).
Eichholtz et al., "A Myristoylated Pseudosubstrate Peptide, a Novel Protein Kinase C Inhibitor*", J.Biol.Chem 268:1982-1986 (1993).
Eidelman et al., "Neurologic Complications of FK 506", Transplnt.Proc. 23:3175-3178 (1991).
Elliot and Chase, "Prevention or delay of Type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide", Diabetologia 34:362-365 (1991).
Ellis et al., "Cyclosporine Improves Psoriasis in a Double-blind Study", JAMA 256:3110-3116 (1986).
Feldt-Rasmussen et al., "Oral cyclosporine for severe chronic idiopathic urticaria and angioedema", Diabetes Medicine 7:429-433 (1990).
Feutren, "Renal Morphology Afteer Cyclosporin A Therapy In Rheumatoid Arthritis Pateints," Br.J.Rheum. 32(suppl 1):65-71 (1993).
Feutren et al., "Cyclosporin Increases The Rate And Length Of Remissions In Insulin-Dependent Diabetes Of Recent Onset", Lancet 2:119-124 (1986).
F.o slashed.rre et al., "An Open Controlled, Randomized Comparison Of Cyclosporine And Azathioprine In The Treatment Of Rheumatoid Arthritis: A Preliminary Report", Arthritis Reheum. 30:88-92 (1987).
Figlin et al., "Session II AIDS/Cancer Therapies", Seminars in Hematology, 29(suppl 1):33-35 (1992).
Fradin et al., "Oral cyclosporine for severe chronic idiopathic urticaria and angioedema", J.Am.Acad.Derm. 25:1065-1067 (1991).
Fung et al., "Adverse Effects Associated With the Use of FK 506", Transplant.Proc. 23:3105-3108 (1991).
Glantz et al., "cAMP Signaling in Neurons: Patterns of Neuronal Expression and Intracellular Localization for a Novel Protein, AKAP 150, that Anchors the Regulatory Subunit of cAMP-Dependent Protein Kinase II.beta.", Mol.Cell.Biol. 3:1215-1228 (1992).
Glantz et al., "Characterization of Distinct Tethering and Intracellular Targeting Domains in AKAP75 a Protein That Links cAMP-dependent Protein Kinase II.beta. to the Cytoskeleton*", J.Biol.Chem. 268:12796-12804 (1993).
Greengard et al., "Enhancement of the Glutamate Response by cAMP-Dependent Protein Kinase in Hippocampal Neurons", Science 253:1135-1138 (1991).
Guerini and Klee, "Cloning of human calcineurin A: Evidence for two isozymes and identification of a polyproline structural domain", Proc.Natl.Acad.Sci.(USA) 86:9183-9187 (1989).
Harlow and Lane, "Immunoaffinity Purification of Antibodies on an Antigen Column", in Antibodies: A Laboratory Manual, Harlow and Lane (eds.) Cold Spring Harbor Laboratory:Cold Spring Harbor, NY (1988), pp. 313-318.
Hashimoto et al., "Identification of an Autoinhibitory Domain in Calcineurin*", J.Biol.Chem. 265:1924-1927 (1990).
Hathaway et al., "Interaction of Calmodulin with Myosin Light Chain Kinase and cAMP-dependent Protein Kinase in Bovine Brain*", J.Biol.Chem. 265:8183-8189 (1981).
Hausken et al., "Type II Regulatory Subunit (RII) of the cAMP-dependent Protein Kinase Interaction with A-kinase Anchor Proteins Requires Isoleucines 3 and 5*", J.Biol.Chem. 269:24245-24251 (1994).
Hirsch et al., "Cloning and Expression of an Intron-less Gene for AKAP 75, an Anchor Protein for the Regulatory Subunit of cAMP-dependent Protein Kinase II.beta.*", J.Biol.Chem. 267:2131-2134 (1992).
Hubbard and Cohen, "On target with a new mechanism for the regulation of protein phosphorylation", T.I.B.S. 17:172-177 (1993).
Hulton et al., "Long-term cyclosporin A treatment

Affiliated with

Also associated with

Rating

PKA-binding proteins and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PKA-binding proteins and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PKA-binding proteins and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1672523